Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-05-17 4:49 pm Purchase |
2021-05-05 | 13G | Spruce Biosciences, Inc. SPRB |
Flynn James E | 1,419,651 6.090% |
1,419,651 (New Position) |
Filing History |
| 2021-05-07 4:56 pm Purchase |
2021-04-27 | 13G | KalVista Pharmaceuticals, Inc. KALV |
Flynn James E | 1,806,037 7.430% |
1,806,037 (New Position) |
Filing History |
| 2021-05-04 12:33 pm Purchase |
2021-05-04 | 13G | Werewolf Therapeutics, Inc. HOWL |
Flynn James E | 2,552,787 9.270% |
2,552,787 (New Position) |
Filing History |
| 2021-04-09 1:19 pm Purchase |
2021-03-30 | 13G | Wave Life Sciences Ltd. WVE |
Flynn James E | 3,910,430 7.980% |
3,910,430 (New Position) |
Filing History |
| 2021-03-30 3:40 pm Purchase |
2021-03-30 | 13G | Edgewise Therapeutics, Inc. EWTX |
Flynn James E | 3,933,137 8.270% |
3,933,137 (New Position) |
Filing History |
| 2021-03-17 11:01 am Purchase |
2021-03-15 | 13G | Xeris Biopharma Holdings, Inc. XERS |
Flynn James E | 12,435,751 9.880% |
6,553,398 (+111.41%) |
Filing History |
| 2021-02-22 4:45 pm Unchanged |
2021-02-18 | 13D | HIGHCAPE CAP ACQUISITION CRP U CAPAU |
Flynn James E | 1,000,000 8.400% |
0 (Unchanged) |
Filing History |
| 2021-02-12 12:41 pm Sale |
2020-12-31 | 13G | DBV Technologies S.A. DBVT |
Flynn James E | 0 0.000% |
-118,900 (Position Closed) |
Filing History |
| 2021-02-12 12:40 pm Sale |
2020-12-31 | 13G | Alimera Sciences, Inc. ALIM |
Flynn James E | 0 0.000% |
-676,667 (Position Closed) |
Filing History |
| 2021-02-12 12:39 pm Sale |
2020-12-31 | 13G | AVEO Pharmaceuticals, Inc. AVEO |
Flynn James E | 0 0.000% |
-1,574,000 (Position Closed) |
Filing History |
| 2021-02-12 12:39 pm Sale |
2020-12-31 | 13G | X4 Pharmaceuticals, Inc. XFOR |
Flynn James E | 457,500 2.730% |
-449,437 (-49.56%) |
Filing History |
| 2021-02-12 12:38 pm Sale |
2020-12-31 | 13G | Vericel Corporation VCEL |
Flynn James E | 64,946 0.140% |
-2,682,617 (-97.64%) |
Filing History |
| 2021-02-12 12:37 pm Sale |
2020-12-31 | 13G | Vapotherm, Inc. VAPO |
Flynn James E | 75,565 2.360% |
-63,889 (-45.81%) |
Filing History |
| 2021-02-12 12:37 pm Purchase |
2020-12-31 | 13G | Sientra, Inc. SIEN |
Flynn James E | 1,655,226 4.985% |
1,232,458 (+291.52%) |
Filing History |
| 2021-02-12 12:36 pm Sale |
2020-12-31 | 13G | Nkarta, Inc. NKTX |
Flynn James E | 1,419,872 4.360% |
-1,000,000 (-41.32%) |
Filing History |
| 2021-02-12 12:35 pm Sale |
2020-12-31 | 13G | Neuronetics, Inc. STIM |
Flynn James E | 919,000 11.000% |
-156,000 (-14.51%) |
Filing History |
| 2021-02-12 12:35 pm Purchase |
2020-12-31 | 13G | Intersect ENT, Inc. XENT |
Flynn James E | 4,438,213 4.985% |
1,641,180 (+58.68%) |
Filing History |
| 2021-02-12 12:34 pm Sale |
2020-12-31 | 13G | Cabaletta Bio, Inc. CABA |
Flynn James E | 464,252 1.930% |
-1,164,252 (-71.49%) |
Filing History |
| 2021-02-12 12:33 pm Sale |
2020-12-31 | 13G | Axonics, Inc. AXNX |
Flynn James E | 800,000 2.010% |
-994,594 (-55.42%) |
Filing History |
| 2021-02-12 12:32 pm Sale |
2020-12-31 | 13G | Ardelyx, Inc. ARDX |
Flynn James E | 10,246,216 2.840% |
-17,770,796 (-63.43%) |
Filing History |